RxDoctor Payments Data

Jeremy Gebhart, MD

Adult Reconstructive Orthopaedic Surgery · Meadville, PANPI 1174967715

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $23,289 of the $28,864 with a category attached, or 80.7%. Medical Device Business Services, Inc. accounts for 90.0% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $10,631, 2.2 times the $4,803 reported in 2019.

$28,864in general payments, 2019–2025

Across 62 payments — averaging $465.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$26K
  • Stryker$2K
  • Johnson & Johnson$662
  • Bioventus LLC$164
  • Microport Orthopedics Inc$104
  • Innovation Technologies Inc$61
  • plus $109 from 2 others

What the payments were for

  • Consulting fees$23,28981%
  • Travel & lodging$3,76713%
  • Food & beverage$1,8086%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$28,864 in reported general payments places this provider in the 80th percentile of 51 adult reconstructive orthopaedic surgery providers in Pennsylvania.

See all adult reconstructive orthopaedic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$368,457
Medicare patients
397
Services billed
2,139

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin421$2,231
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen232$2,086
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen124$1,179
Methylprednisolone192$1,062
Tramadol Hcl179$475
Meloxicam49$196
Amoxicillin121$102
Clindamycin Hcl20$18

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Meadville

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →